Inês Martins, PhD, managing science editor —

Inês holds a PhD in biomedical sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied cell and molecular biology and worked as a research fellow at multiple institutes. In addition to several college awards, Inês won the Pfizer Basic Research Award in 2012 for a research paper. She also has a graduate degree in data science.

Articles by Inês Martins

Microfluidic Device May Replace Bone Marrow Biopsies for Myeloma

Patients with multiple myeloma soon may be diagnosed and followed solely with the use of a blood sample, avoiding the painful process of collecting a bone marrow biopsy. Researchers at the Massachusetts Institute of Technology (MIT) have developed a microfluidic device that grabs plasma cells — the myeloma cancer cells —…

FDA Grants Tasquinimod Orphan Drug Status to Treat Multiple Myeloma

The small molecule immunomodulatory drug tasquinimod has been designated an orphan drug by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma, according to Active Biotech. Tasquinimod has been developed primarily for the treatment of prostate cancer, but its mechanism of action suggests that it could be…